Why LifeMD, Inc.’s (LFMD) Stock Is Down 5.32%
As of Wednesday, August 12, LifeMD, Inc.’s LFMD share price has dipped by 5.32%, which has investors questioning if this is right time to buy.Rosalio Madrigal
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Rosalio Madrigal
Cynthia McLaughlin
Jenna Brashear
Rosalio Madrigal
Jenna Brashear
| Share Statistics | LFMD | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $148.0 | $218.2 | 25% |
|
| Shares Out (Mil) | 47.8 | 47.8 | 46% |
|
| Institutional Ownership | 76.1% | 79.3% | 46% |
|
| Float (Mil) | 39.7 | 39.7 | 42% |
|
| Beta | 2.06 | 1.22 | 93% |
|
| Avg Daily Volume (000s) | 524 | 283 | 60% |
|
| Price Change (52-week) |
(50.2%) | 46.7% | 15% |
|
| Growth | LFMD | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 39.1% | 11.8% | 93% |
|
| Net Income (5yr) | 17.6% | 2.7% | 69% |
|
| EPS (5yr) | 15.5% | 15.5% | 58 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (41.2%) | (15.8%) | 11% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 2 | 2 | 2 | |
| Current EPS | ($0.005) | ($0.165) | $0.380 | |
| Month Ago EPS | $0.170 | $0.135 | $0.515 | |
| # Rev Up | 1 | 1 | 0 | |
| # Rev Down | 0 | 1 | 1 | |
| Three Months Ago EPS | $0.170 | $0.135 | $0.515 | |
| Year/Year Chg | (97.0%) | (49.1%) | (272.8%) | |
| Financials | LFMD | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $192 | $202 | 32% |
|
| Net Income (TTM) (Mil) | $0 | ($9) | 39% |
|
| EPS (TTM) | ($0.062) | ($0.600) | 37% |
|
| Operating Cash Flow (TTM) (Mil) | ($7) | ($1) | 23% |
|
| Net Cash Flow (TTM) (Mil) | ($11) | $3 | 30% |
|
| Long-Term Debt (Q1) (Mil) | $5 | $18 | 25% |
|
| Enterprise Value (Q1) (Mil) | $138 | $171 | 23% |
|
| Valuation | LFMD | Industry Median |
Percentile (All Stocks) |
|
| P/B | 18.06 | 1.25 | 95% |
|
| P/E | na | 41.4 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 2.5 | na |
|
| Ratios | LFMD | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 87.5% | 61.6% | 93% |
|
| Net Margin | 0.1% | (24.1%) | 32% |
|
| ROA | 0.3% | (21.8%) | 40% |
|
| ROE | 6.5% | (6.7%) | 47% |
|
| Liabilities to Assets | 86.7% | 32.1% | 80% |
|
| F-Score | 4 | 4 | na |
|
LifeMD, Inc. did not pass any screens on 9/2/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors